We are Sorry, This Page doesn't Exist
Roche Boosts Diagnostics Portfolio With $1.8B Bet On COVID-19 Test Manufacturer GenMark
Swiss drug giant Roche Holding AG (OTC: RHHBY) announced a big-ticket acquisition that would boost its presence in the diagnostics market, setting the tempo for a merger Monday. read more.....»»
New data on Eli Lilly"s experimental Alzheimer"s drug backs a hotly debated scientific theory, but shows mixed benefits for patients
Eli Lilly's treatment reduced a harmful substance in the brains of patients with Alzheimer's disease and slowed their rate of cognitive decline. Patients sit inside the Alzheimer's Foundation in Mexico City Thomson Reuters Eli Lilly's.....»»
: Novavax stock rallies on COVID-19 vaccine study results
Novavax Inc. NVAX shares rallied in the extended session Thursday after the biotech drug maker said studies show its COVID-19 vaccine is highly effective. Novavax shares surged 17% after hours,.....»»
Merck to buy drug developer Pandion Therapeutics for $1.85B
Pandion’s lead drug candidate, PT101, last month met its main goals of safety and tolerability in an early-stage trial in patients with autoimmune diseases......»»
GSK to refocus study of experimental COVID-19 antibody treatment on patients 70 and older
Shares of GlaxoSmithKline were down 0.2% in trading on Thursday after the drug maker said its experimental monoclonal antibody treatment did not meet the primary endpoint in a mid-stage trial evaluating its use in hospitalized COVID-19 patients of all a.....»»
Number of medical marijuana patients reaches new high
There are 100,000 certified medical marijuana patients in Massachusetts, the highest number of patients using medical marijuana since the drug was legalized for medical purposes in 2012. The number of patients using medical marijuana has grow.....»»
Roche arthritis drug reduced Covid deaths in study, Reuters reports
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fecal transplants, made up of poop and microbes, are being touted as a promising new treatment for skin cancer patients
A new study suggests that transplanting fecal matter into the guts of melanoma patients could help them respond better to immunotherapy. Fecal transplants, which are made up of poop an.....»»
PhaseBio patients completed Phase 1b/2a study of PB1046 with no drug-related SEs
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Durham drugmaker ends Covid-19 program despite millions in federal funding
A Triangle company that had been awarded tens of millions worth of federal contracts to study its drug's potential for treating Covid-19 patients says it's ending those efforts......»»
Why These 4 Health Care Stocks Are Moving Today
Osmotica Pharmaceuticals (NASDAQ: OSMT) shares were trading higher Monday in anticipation of a ruling by the FDA on the company's New Drug Application for Arbaclofen ER in patients with multiple sclerosis. read more.....»»
There"s a clear way Biden can immediately take on the pharmaceutical industry and bring down drug prices for all Americans
A new economic analysis shows how anti-competitive industry practices keep drug prices high and hurt patients Hiraman/Getty Images Rebates offered by drug makers incentivize insurance companies to cover some drugs over ot.....»»
: Penumbra stock falls on recall of blood-clot-removing catheter
Penumbra Inc. PEN shares fell in the extended session Tuesday after the medical device maker recalled a type of catheter used for removing blood clots in stroke patients that could cause injury or death. Penumbra shares fell.....»»
U.S. regulator is reviewing Abbott"s fast COVID test after studies raise accuracy concerns
The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories’ speedy coronavirus test, which can deliver results within minutes and is used at the White House, could potentially be inaccurate but can still be used to test patients......»»
GW Pharmaceuticals sells more of CBD-derived epilepsy drug than expected, stock rises
GW Pharmaceuticals PLC shares rose 2.6% in the extended session Monday after the U.K.-based company sold much more of its cannabis derived epilepsy d.....»»
A new study finds that people who are dying from coronavirus potentially lose at least 10 years of their lives
create jobs 51/Shutterstock A recent study conducted by the University of Glasgow's researchers found that COVID-19 patients might have lasting health impacts. In fact, an average male can lose.....»»
Raleigh pharma to study coronavirus treatment on patients in U.S.
A Triangle drugmaker that's seen positive results with its Covid-19 treatment internationally can now start treating patients in the U.S. Raleigh's RedHill Biopharma (Nasdaq: RDHL) has received approval from the U.S. Food and Drug Administration .....»»
Government to test remdesivir with Lilly drug in COVID-19 patients
The National I.....»»
The same number of people could die from ‘deaths of despair’ as have already died in the U.S. from coronavirus, new study finds
‘More Americans could lose their lives to deaths of despair, deaths due to drug, alcohol, and suicide, if we do not do something immediately.’.....»»
Hospitals are stuck waiting for supplies of a promising coronavirus treatment to arrive, days after health authorities OK"d its emergency use
Associated Press A promising coronavirus treatment called remdesivir was approved last week for emergency use in the US. Now, some hospitals are having a hard time getting the drug for their patients. The US government is deciding which hospitals will .....»»